109 related articles for article (PubMed ID: 6668495)
1. The in vivo effect of thymic factor (thymostimulin) administration on circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease patients.
Velardi A; Spinozzi F; Rambotti P; Tabilio A; Losito A; Zampi I; Cernetti C; Martelli MF; Grignani F; Davis S
J Clin Oncol; 1983 Feb; 1(2):117-25. PubMed ID: 6668495
[TBL] [Abstract][Full Text] [Related]
2. Circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease. Their relationship to immune function.
Spinozzi F; Velardi A; Rambotti P; Losito A; Zampi I; Cernetti C; Gerli R; Martelli MF; Grignani F
J Clin Lab Immunol; 1983 Oct; 12(2):87-92. PubMed ID: 6644793
[TBL] [Abstract][Full Text] [Related]
3. The in vivo effect of thymic factor (thymostimulin) administration in Hodgkin's disease patients. Correlation of skin reactivity and leukocyte migration-inhibition factor in the sera of anergic subjects.
Velardi A; Rambotti P; Cernetti C; Spinozzi F; Bertotto A; Martelli MF
Thymus; 1983 Sep; 5(5-6):429-32. PubMed ID: 6362105
[TBL] [Abstract][Full Text] [Related]
4. The in vivo effect of a thymic factor (thymostimulin) on immunologic parameters of patients with untreated Hodgkin's disease.
Martelli MF; Velardi A; Rambotti P; Cernetti C; Bertotto A; Spinozzi F; Bracaglia AM; Falini B; Davis S
Cancer; 1982 Aug; 50(3):490-7. PubMed ID: 7046903
[TBL] [Abstract][Full Text] [Related]
5. The in vitro effect of a calf thymus extract (thymostimulin) on the immunologic parameters of patients with untreated Hodgkin's disease.
Martelli MF; Velardi A; Rambotti P; Cernetti C; Bracaglia AM; Ballatori E; Davis S
Cancer; 1982 Jan; 49(2):245-50. PubMed ID: 7053826
[TBL] [Abstract][Full Text] [Related]
6. Circulating immune complexes (CIC) in Hodgkin's disease. I. Levels and two-dimensional analysis.
Nerurkar AV; Advani SH; Gothoskar BP
Neoplasma; 1989; 36(2):199-205. PubMed ID: 2716924
[TBL] [Abstract][Full Text] [Related]
7. Influence of splenectomy on the levels of circulating immune complexes (CIC) in Hodgkin's disease (HD).
Nerurkar AV; Advani SH; Gothoskar BP
Neoplasma; 1987; 34(1):89-93. PubMed ID: 3561608
[TBL] [Abstract][Full Text] [Related]
8. Circulating immune complexes, complement and complement component levels in childhood Hodgkin's disease.
Brandeis WE; Tan C; Wang Y; Good RA; Day NK
Clin Exp Immunol; 1980 Mar; 39(3):551-61. PubMed ID: 7379328
[TBL] [Abstract][Full Text] [Related]
9. Reaction of immune complexes with Hodgkin's disease tissue cultures: radioimmune assay and immunoferritin electron microscopy.
Long JC; Dvorak AM; Quay SC; Stamatos C; Chi SY
J Natl Cancer Inst; 1979 Apr; 62(4):787-97. PubMed ID: 372654
[TBL] [Abstract][Full Text] [Related]
10. Circulating immune complexes in Hodgkin's disease.
Brown CA; Hall CL; Long JC; Carey K; Weitzman SA; Aisenberg AC
Am J Med; 1978 Feb; 64(2):289-94. PubMed ID: 629278
[TBL] [Abstract][Full Text] [Related]
11. [Circulating immune complexes in the serum in Hodgkin's disease].
Nikolić V; Zivanović L; Banićević B; Milosević-Jovcić N
Bilt Hematol Transfuz; 1980; 8(1):19-27. PubMed ID: 7337679
[TBL] [Abstract][Full Text] [Related]
12. The immunopathology of Hodgkin's disease.
Long JC
Clin Haematol; 1979 Oct; 8(3):531-66. PubMed ID: 159150
[TBL] [Abstract][Full Text] [Related]
13. Circulating immune complexes in sarcoidosis.
Selroos O; Klockars M; Kekomäki R; Pentinen K; Lindström P; Wager O
J Clin Lab Immunol; 1980 Mar; 3(2):129-32. PubMed ID: 6259356
[TBL] [Abstract][Full Text] [Related]
14. Binding of soluble immune complexes in serum of patients with Hodgkin's disease to tissue cultures derived from the tumor.
Long JC; Hall CL; Brown CA; Stamatos C; Weitzman SA; Carey K
N Engl J Med; 1977 Aug; 297(6):295-9. PubMed ID: 559938
[TBL] [Abstract][Full Text] [Related]
15. An enzyme-linked immunoassay for detection of IgG- and C3-containing circulating immune complexes: comparison with a radioimmunoassay and quantitation in patients with rheumatic diseases.
Panush RS; Somberg LB; Katz P; Longley S
Diagn Immunol; 1983; 1(4):288-94. PubMed ID: 6388973
[TBL] [Abstract][Full Text] [Related]
16. Circulating immune complexes in Hodgkin's disease.
Akolkar PN; Advani SH; Gothoskar BP
Neoplasma; 1983; 30(1):73-9. PubMed ID: 6835441
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor.
Weihrauch MR; Manzke O; Beyer M; Haverkamp H; Diehl V; Bohlen H; Wolf J; Schultze JL
Cancer Res; 2005 Jul; 65(13):5516-9. PubMed ID: 15994922
[TBL] [Abstract][Full Text] [Related]
18. Serum angiotensin-I-converting enzyme and lysozyme levels in untreated and unsplenectomized patients with Hodgkin's disease.
Bosi A; Borsotti M; Ghelli P; Tozzi P; Bellesi G; Rossi Ferrini P
Acta Haematol; 1984; 71(5):329-33. PubMed ID: 6331045
[TBL] [Abstract][Full Text] [Related]
19. [Circulating immune complexes in malignant tumors].
Savina NP
Sov Med; 1989; (8):8-10. PubMed ID: 2814673
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial to evaluate the immunorestorative properties of thymostimulin in patients with Hodgkin's disease in complete remission.
Liberati AM; Ballatori E; Fizzotti M; Schippa M; Cini L; Cinieri S; Proietti MG; Di Marzio R; Senatore M; Grignani F
Cancer Immunol Immunother; 1988; 26(1):87-93. PubMed ID: 3125973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]